• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿司匹林用于预防全髋关节置换术后异位骨化:初步报告

The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report.

作者信息

Freiberg A A, Cantor R, Freiberg R A

机构信息

Department of Orthopaedic Surgery, University of Cincinnati College of Medicine, Ohio.

出版信息

Clin Orthop Relat Res. 1991 Jun(267):93-6.

PMID:1904336
Abstract

The reported incidence of heterotopic ossification (HO) after total hip arthroplasty (THA) ranges up to 50%. HO causes pain and restricted range of motion (ROM) in a significant number of these THA patients. From 1983 to 1988, 177 primary cemented THAs were performed in 131 consecutive patients. Six hundred fifty milligrams of buffered aspirin administered twice daily for two weeks was used as a prophylaxis for thromboembolic disease. There was an unusually low incidence of HO in this group of patients. Aspirin treatment was instituted the night before surgery and continued for two weeks, except in 13 patients (7%) who had to stop treatment because of gastrointestinal symptoms. All patients had at least one year of roentgenographic study postoperatively. According to the Brooker Classification of HO, there were 169 (96%) Grade I and Grade 0 hips, six (3%) Grade II, two (1%) Grade III, and no Grade IV. None of the patients had symptomatic restriction of ROM attributable to heterotopic bone. Aspirin is a safe and inexpensive agent for prevention of HO after THA.

摘要

据报道,全髋关节置换术(THA)后异位骨化(HO)的发生率高达50%。在大量接受THA手术的患者中,HO会导致疼痛和活动范围(ROM)受限。1983年至1988年,对131例连续患者进行了177例初次骨水泥型THA手术。每天两次服用650毫克缓冲阿司匹林,持续两周,作为预防血栓栓塞性疾病的措施。该组患者中HO的发生率异常低。阿司匹林治疗在手术前一晚开始,持续两周,但有13例患者(7%)因胃肠道症状不得不停止治疗。所有患者术后至少进行了一年的X线检查。根据布鲁克(Brooker)HO分类法,有169例(96%)髋关节为I级和0级,6例(3%)为II级,2例(1%)为III级,无IV级。没有患者因异位骨导致有症状的ROM受限。阿司匹林是预防THA后HO的一种安全且廉价的药物。

相似文献

1
The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report.阿司匹林用于预防全髋关节置换术后异位骨化:初步报告
Clin Orthop Relat Res. 1991 Jun(267):93-6.
2
The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.异位骨化对全髋关节置换术后髋关节功能状态的影响。
Strahlenther Onkol. 2005 Aug;181(8):529-33. doi: 10.1007/s00066-005-1352-4.
3
Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high-risk patients.在高危患者中使用低剂量辐射预防全髋关节置换术后异位骨形成。
Clin Orthop Relat Res. 1992 Jul(280):230-4.
4
Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.全髋关节置换术中的异位骨形成:诱发因素、分类及其对临床结局的意义。
Acta Chir Orthop Traumatol Cech. 2001;68(2):105-8.
5
Shielding of the hip prosthesis during radiation therapy for heterotopic ossification is associated with increased failure of prophylaxis.在针对异位骨化的放射治疗期间对髋关节假体进行屏蔽与预防失败率增加相关。
Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1499-505. doi: 10.1016/j.ijrobp.2006.11.007. Epub 2007 Jan 17.
6
Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.全髋关节置换术。抗炎药物在预防异位骨化中的作用。
Clin Orthop Relat Res. 1991 Feb(263):78-86.
7
Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.与接受华法林治疗的患者相比,接受阿司匹林治疗的患者在全髋关节置换术后异位骨化较少。
Bull NYU Hosp Jt Dis. 2010;68(4):266-72.
8
Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.罗非昔布和吲哚美辛对髋关节置换术后异位骨化发生率的相似影响。
Acta Orthop. 2007 Feb;78(1):90-4. doi: 10.1080/17453670610013475.
9
Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis.阿司匹林可降低骨关节炎一期双侧全髋关节置换术后异位骨化的发生率和严重程度。
J Arthroplasty. 2009 Feb;24(2):226-32. doi: 10.1016/j.arth.2007.11.008. Epub 2008 Mar 28.
10
[Prevention of heterotopic ossification by radiotherapy following total hip prosthesis].全髋关节置换术后放疗预防异位骨化
Dtsch Med Wochenschr. 1995 Jul 14;120(28-29):983-9. doi: 10.1055/s-2008-1055435.

引用本文的文献

1
Involvement of the Wnt/β-catenin signalling pathway in heterotopic ossification and ossification-related diseases.Wnt/β-catenin 信号通路在异位骨化和骨化相关疾病中的作用。
J Cell Mol Med. 2024 Sep;28(18):e70113. doi: 10.1111/jcmm.70113.
2
Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification.用于全髋关节置换术中预防静脉血栓栓塞的阿司匹林可减少异位骨化。
Arthroplast Today. 2020 Mar 13;6(2):206-209. doi: 10.1016/j.artd.2020.01.010. eCollection 2020 Jun.
3
Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
非甾体类抗炎药用于全髋关节置换术后异位骨化的预防:一项系统评价和荟萃分析
Medicine (Baltimore). 2015 May;94(18):e828. doi: 10.1097/MD.0000000000000828.
4
Thromboembolic prophylaxis in total joint arthroplasty.全关节置换术中的血栓栓塞预防
Thrombosis. 2012;2012:837896. doi: 10.1155/2012/837896. Epub 2012 Sep 16.
5
Aspirin decreases heterotopic ossification after hip resurfacing.阿司匹林可降低髋关节表面置换术后异位骨化。
Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.
6
Prevention of heterotopic ossification after total hip replacement with NSAIDs.非甾体抗炎药预防全髋关节置换术后异位骨化
Pharm World Sci. 2003 Aug;25(4):138-45. doi: 10.1023/a:1024830213832.
7
[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].[全髋关节置换术后异位骨化预防的前瞻性研究。非甾体类抗炎药与放射治疗的比较]
Strahlenther Onkol. 1997 Dec;173(12):677-82. doi: 10.1007/BF03038450.